Trademark: REZLIDHIA
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for REZLIDHIA
We do not have any records of a proof of use for REZLIDHIA at this moment.
Possible trademark infringements of REZLIDHIA
Basic Information about REZLIDHIA
- Serial Number
- 88603967
- Filing Date
- 04 Sep 2019
- Registration Number
- 7031333
- Registration Date
- 18 Apr 2023
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of REZLIDHIA on the blockchain with WikiTrademarks.io.
- First use of REZLIDHIA anywhere
- REZLIDHIA was first used on 11 Dec 2022 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 005; 006; 018; 044; 046; 051; 052
Who owns REZLIDHIA?
1. RIGEL PHARMACEUTICALS, INC. South San Francisco CA
2. RIGEL PHARMACEUTICALS, INC. South San Francisco CA
3. Forma Therapeutics, Inc. Watertown MA
4. Forma Therapeutics, Inc. Watertown MA
Correspondent
- Diane J. Mason
- FAEGRE DRINKER BIDDLE & REATH LLP
- FOUR EMBARCADERO CENTER, 27TH FLOOR
- SAN FRANCISCO, CA 94111
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io